Altimmune (ALT) IV ramping with 2000 August $13 calls bought $1.35/$1.40 and has some notable OI in Sep. $12 and Dec. $10 calls. ALT shares on a strong run since May Phase 1b NAFLD data in Q3 and interim Phase 2b obesity in Q4 upcoming key catalysts that can push shares higher and lead to strategic partnerships